GO
Loading...

Gilead Sciences Inc

More

  • Final Glance: Biotechnology companies Wednesday, 23 Apr 2014 | 6:03 PM ET

    Amgen Inc. fell $5.99 or 5.0 percent, to $113.32. Biogen Idec rose$. 55 or. 2 percent, to $306.75. Celgene Corp. fell $1.82 or 1.2 percent, to $144.82.

  • US STOCKS-Wall St snaps six-day run; Apple to split stock Wednesday, 23 Apr 2014 | 5:19 PM ET

    *AT&T falls after results, but Boeing rallies. *Amgen drags biotech lower, but Gilead gains. NEW YORK, April 23- U.S. stocks dipped on Wednesday to snap a six-session winning streak as gains in Boeing and Gilead were offset by slides in AT&T and the wider biotech sector.

  • *AT&T falls after results, but Boeing rallies. *Amgen drags biotech lower, but Gilead gains. NEW YORK, April 23- U.S. stocks dipped on Wednesday to snap a six-session winning streak as gains in Boeing and Gilead were offset by slides in AT&T and the wider biotech sector.

  • *AT&T falls after results, but Boeing rallies. *Amgen drags biotech lower, but Gilead gains. NEW YORK, April 23- U.S. stocks declined on Wednesday after a six-session winning streak as gains in Boeing and Gilead were offset by slides in AT&T and the wider biotech sector.

  • Most active Nasdaq-traded stocks Wednesday, 23 Apr 2014 | 1:37 PM ET

    Cisco Systems Inc. fell. 3 percent to $23.45 with 12,844,500 shares traded. Facebook Inc. fell 2.4 percent to $61.52 with 42,143,300 shares traded. Gilead Sciences Inc. rose 3.3 percent to $75.28 with 20,613,200 shares traded.

  • Midday Glance: Biotechnology companies Wednesday, 23 Apr 2014 | 1:37 PM ET

    Amgen Inc. fell $6.17 or 5.2 percent, to $113.13. Biogen Idec fell $5.61 or 1.8 percent, to $300.59. Celgene Corp. fell$. 59 or. 4 percent, to $146.05.

  • *AT&T falls after results, but Boeing rallies. *Amgen drags biotech lower, but Gilead gains. NEW YORK, April 23- U.S. stocks edged lower on Wednesday as weakness in AT&T and biotech names inspired investors to take profits following six straight days of gains, though a rally in Boeing limited losses.

  • Early Glance: Biotechnology companies Wednesday, 23 Apr 2014 | 10:29 AM ET

    Amgen Inc. fell $5.56 or 4.7 percent, to $113.74. Biogen Idec fell $5.05 or 1.6 percent, to $301.16. Celgene Corp. fell$. 18 or. 1 percent, to $146.46.

  • US STOCKS-Wall St edges lower following six-day S&P rally Wednesday, 23 Apr 2014 | 10:17 AM ET

    *Boeing rallies after results, outlook; AT&T drops. NEW YORK, April 23- U.S. stocks edged lower on Wednesday as strong results from Boeing failed to inspire investors to keep pushing equities higher following six straight days of gains.

  • US stocks edge lower after a six-day rise Wednesday, 23 Apr 2014 | 9:27 AM ET

    NEW YORK— Stocks edged mostly lower Wednesday, breaking a six-day winning streak, as investors were disappointed by the latest round of earnings from U.S. companies. "The market, even with those six days of gains, is still struggling to choose a direction," said Joseph Tanious, a global market strategist with J.P.

  • US STOCKS-Futures imply lower open after recent rally Wednesday, 23 Apr 2014 | 8:41 AM ET

    *Boeing rallies after results, outlook; P&G edges down. *Key earnings on tap; Apple, Facebook out after the close. *Boeing Co reported first-quarter revenue that beat expectations and lifted its core earnings forecast to reflect a tax settlement gain, sending shares up 2.7 percent to $131.05 in premarket trading.

  • US STOCKS-Futures flat after six straight days of gains Wednesday, 23 Apr 2014 | 7:41 AM ET

    *Gilead Sciences rises in premarket after results. *Key earnings on tap; Apple, Facebook out after the close. *Gilead Sciences Inc rose 3.8 percent to $75.60 in heavy premarket trading a day after the drugmaker reported a sharp increase in its quarterly profit, helped by sales of its hepatitis C drug.

  • Gilead says 1Q sales of Sovaldi totaled $2.27B Tuesday, 22 Apr 2014 | 5:41 PM ET

    NEW YORK— Gilead Sciences said Tuesday that sales of its hepatitis C pill Sovaldi totaled more than $2 billion in its first full quarter on the market, and it said quarterly net income tripled. The company reported $2.27 billion in first-quarter sales of Sovaldi, which was launched in the U.S. during December and was approved in Europe in January.

  • April 22- Gilead Sciences Inc, which ignited a fierce debate over prescription drug prices, said its new $1,000 hepatitis C pill generated quarterly sales of $2.27 billion, helping the company's quarterly net profit nearly triple.

  • April 22- Gilead Sciences Inc, whose pricing policy ignited a fierce debate over prescription drug prices, said its new $1,000 hepatitis C pill generated quarterly sales of $2.27 billion, helping the company's quarterly net profit nearly triple.

  • Final Glance: Biotechnology companies Monday, 21 Apr 2014 | 6:02 PM ET

    Amgen Inc. rose $1.56 or 1.4 percent, to $117.02. Biogen Idec rose $7.44 or 2.6 percent, to $297.98. Celgene Corp. rose $2.32 or 1.6 percent, to $143.83.

  • Value stocks to stay in vogue, as momentum fades Monday, 21 Apr 2014 | 5:41 PM ET

    With the wipeout in growth stocks, many investors turned their attention to big-cap and value names, and the trend is expected to continue.

  • Ackman, Valeant pursuing takeover of Allergan Monday, 21 Apr 2014 | 4:46 PM ET
    Bill Ackman

    Activist investor William Ackman of Pershing Square Capital and Valeant Pharmaceuticals International are said to be pursuing a takeover of Allergan.

  • Midday Glance: Biotechnology companies Monday, 21 Apr 2014 | 1:20 PM ET

    Amgen Inc. rose$. 89 or. 8 percent, to $116.35. Biogen Idec rose $3.44 or 1.2 percent, to $293.98. Celgene Corp. rose $1.03 or. 7 percent, to $142.54.

  • Most active Nasdaq-traded stocks Monday, 21 Apr 2014 | 1:20 PM ET

    Cisco Systems Inc. rose. 8 percent to $23.40 with 38,516,700 shares traded. Facebook Inc. rose 3.9 percent to $61.24 with 58,657,400 shares traded. FuelCell Energy Inc. rose 2.9 percent to $2.52 with 17,673,900 shares traded.

Most Popular Video

Wednesday, 23 Apr 2014 | 10:50 PM ET

Taro Kono, Member of the House of Representatives in Japan's Parliament, says the Liberal Democratic Party (LDP) stands behind Prime Minister Shinzo Abe in pushing for the TPP trade deal.

Wednesday, 23 Apr 2014 | 10:34 PM ET

Charles Li, Chief Executive of Hong Kong Exchanges and Clearing, says the launch of a new commodity trading platform for three metal contracts will facilitate long-term cross-border investments.

Wednesday, 23 Apr 2014 | 10:16 PM ET

David Garrity, Principal at GVA Research, says Apple's decision to raise its dividend and step up its stock buyback program signaled confidence in the tech giant's outlook.